Navigation

Mucin-like carcinoma-associated antigen (MCA)

Mucin-like carcinoma-associated antigen (MCA)

The indications of mucin-like carcinoma-associated antigen (MCA) test is the monitoring of flow and detection of recurrence of breast carcinoma. Mucin-like carcinoma-associated antigen (MCA) is a mucin-glycoprotein with a molecular mass 350-500 kDa.

Normal value of mucin-like carcinoma-associated antigen (MCA) — 11 IU/ml.

Elevated levels of mucin-like carcinoma-associated antigen (MCA) is observed in the serum of patients with breast cancer. This increase often correlates with the stage of disease. Elevated levels of mucin-like carcinoma-associated antigen (MCA) is recorded in pregnant women (from 4 month) and in 20% of cases of benign liver diseases and mastopathy.

It is not advisable combined use mucin-like carcinoma-associated antigen (MCA) test and CA 15-3 or CA 549 tests, since in this case the diagnostic sensitivity is not increased. In order to increase the sensitivity desired combination with carcinoembryonic antigen (CEA).